# XARELTO
> **NDA202439** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2011-11-04
## Drug
- **FDA Application Number:** NDA202439
- **Application type:** New Drug Application
- **Brand name:** XARELTO
- **Generic name:** Rivaroxaban
- **Active ingredients:** RIVAROXABAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PHARMS
- **First approval:** 2011-11-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202439)
---
*AI Analytics · CC0 1.0*